Delivery Order SPE2DB22D2211-SPE2DB24FNTT9

Award Date 6/19/24
Potential Completion Date 6/20/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,362.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, and has a completion date of July 12, 2024. The contract is a Delivery Order under the terms of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $1,303.16, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a medical product, with a completion date of November 25, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract is a Delivery Order valued at $6,155.68 with a firm fixed price and an ultimate completion date of June 11, 2024. The contract has no set-aside designation, indicating it was open to all qualified vendors....
This federal contract award, valued at $1,401.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 9, 2023 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc.,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,943.06, is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 30, 2023. The contract is not set aside for any specific type of business. AmerisourceBergen Drug Corp holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,425.52, is a delivery order for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,878.58 firm-fixed-price delivery order is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a prescription medication. The contract has a completion date of September 6, 2024. AmerisourceBergen is delivering these pharmaceutical products under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $1,161.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of April 24, 2025 and was awarded on April 23, 2025. It is not designated as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,197.07 delivery order covers the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with a performance period through May 16, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $2,169.66 and a completion date of July 12, 2024. The contract was awarded on July 11, 2024 and does not have a set-aside designation, indicating open competition....
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FNTT9
    Delivery Order

This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,472.07, is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of June 20, 2024. The contract was awarded on June 19, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and there are no major subcontractors mentioned. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:04 AM